For people with type 2 diabetes, insufficient medication doses can lead to poor blood sugar control, potentially causing long-term complications like nerve damage, kidney problems, or cardiovascular issues
These are pathway-level markers they do not predict response to any specific medication and are not a pharmacogenomic test, but they add context a licensure check cannot
The recognition strengthened the case for lower prices and wider access in lower-income countries, where most people with diabetes live but many remain untreated
While taking GLP-1 medications, its advisable to avoid foods that can cause rapid spikes in blood sugar levels or lower the medications effectiveness, such as: sugary foods and beverages like juices, soda, and alcohol refined carbohydrates like white bread and pasta high fat foods like baked goods and fried foods A GLP-1 medications can help reduce cravings for nutrient-poor foods
These medication-specific considerations highlight the importance of tailoring treatment plans for vulnerable CKD populations
This is the step that intimidates most beginners
